Urology Day 2

Moderator(s)

• VB

  VICTORIA BIRD, M.D.

  Director
  NATIONAL MEDICAL ASSOCIATION AND RESEARCH GROUP
  GAINESVILLE, Florida, United States
• 

  Brian Miles

Panelist(s)

• 

  Ryochi Shiroki
• 

  Sanjay Razdan, MD MCh FRCS (Glasg)

  Professor and Chair,
  International Robotic Institute for Prostate Cancer
  Doral, Florida, United States
• 

  Kunihiko Yoshioka, MD, PhD

  Urologist
  Department of Urology, Itabashi Chuo Medical Center, Tokyo, Japan

Presentations:

• 1:30 PM - 1:45 PM CEST

  State of the Art Lecture: Literature Review: Important Prostate Cancer Publications From 2024-2025
  

  Speaker: Chiara Sighniofli
• 1:45 PM - 2:00 PM CEST

  Session 1: Different Technical Approaches to RALP: Transperitoneal Anterior Approach Robotic Radical Prostatectomy
  

  Speaker: Richard Gaston
• 2:00 PM - 2:15 PM CEST

  Session 1: Different Technical Approaches to RALP: Retzius RALP
  

  Speaker: Aldo Bocciardi
• 2:15 PM - 2:30 PM CEST

  Session 1: Different Technical Approaches to RALP: Single Port Retroperitoneal RALP
  

  Speaker: Jean Joseph
• 2:30 PM - 2:45 PM CEST

  Session 1: Different Technical Approaches to RALP: Transvesical Single Port RALP
  

  Speaker: John Davis
• 2:45 PM - 2:55 PM CEST

  Session 1: Different Technical Approaches to RALP: Panel Discussion: What’s the Optimal Technique and When and How to Use It
• 2:55 PM - 3:10 PM CEST

  Session 2: Important Trends in Prostate Cancer: State of the Art Lecture: Oncologic Trends in Prostate Cancer
  

  Speaker: Rafael Coelho
• 3:10 PM - 3:40 PM CEST

  Session 2: Important Trends in Prostate Cancer: Panel Discussion: The Changing Paradigm of Prostate Cancer: Key Questions:Are We Over Screening or Underscreening? Are Outcomes getting Better or Worse? Is Active Surveillance Working or Making the Long Term Outcomes worse? What guidelines needs to change? Is prostate imaging changing the game? Is neoadjuvant therapy effecting prostate ca outcomes? Single port surgery: What are the benefits and the challenges?
• 3:40 PM - 4:00 PM CEST

  Session 3: State of the Art Lecture: RALP, The Journey to 20K lessons learned
  

  Speaker: Vipul R. Patel, Medical Director, Global Robotics Institute
• 4:00 PM - 4:10 PM CEST

  Session 3: Improving RALP Outcomes:Prediction of ECE: Updates on NeuroSAFE, Histology Scanners, Nomograms, Imaging and AI
  

  Speaker: Dave Albala
• 4:10 PM - 4:20 PM CEST

  Session 3: Improving RALP Outcomes: Nerve Sparing RALP: The Key Concepts for full and partial nerve sparing
  

  Speaker: Rafael Coelho
• 4:20 PM - 4:30 PM CEST

  Session 3: Improving RALP Outcomes: Nerve Sparing RALP- The Key Concepts for earlier continence recovery
  

  Speaker: Bernardo Rocco
• 4:30 PM - 4:40 PM CEST

  Session 3: Improving RALP Outcomes: NARUS Lecture: Surgical Management of High Risk Prostate Cancer and Oligometastatic disease: are we making a difference?
  

  Speaker: John Davis
• 4:40 PM - 4:50 PM CEST

  Status of Active Surveillance
  

  Speaker: Laurence Klotz
• 4:50 PM - 5:00 PM CEST

  Status of Extended Pelvic Lymph Node Dissection
  

  Speaker: Ben Challacombe
• 5:00 PM - 5:10 PM CEST

  Panel Discussion
• 5:10 PM - 5:25 PM CEST

  Session 5: New Innovations in Prostate Therapies: Prostate Biopsy: What's the best approach and the ideal imaging modality
  

  Speaker: Angel Alvarado
• 5:25 PM - 5:40 PM CEST

  Session 5: New Innovations in Prostate Therapies: The current role of focal therapy in low/intermediate risk prostate cancer
  

  Speaker: Eric Barret
• 5:40 PM - 5:55 PM CEST

  Aquablation: A new therapy for BPH and potential application in prostate cancer
  

  Speaker: Ben Challacombe
• 5:55 PM - 6:00 PM CEST

  Panel Discussion